A61P 37/08
Antiallergic agents
Official title: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
A61P37/08 (Antiallergic agents) appears on 14,849 US grants and 20,556 published applications in this corpus.
Search patents in A61P- Granted patents
- 14,849
- Published applications
- 20,556
- Assignees
- 4,993
- Inventors
- 31,770
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 11 | 0 |
| 1978 | 24 | 0 |
| 1979 | 19 | 0 |
| 1980 | 31 | 0 |
| 1981 | 36 | 0 |
| 1982 | 33 | 0 |
| 1983 | 33 | 0 |
| 1984 | 52 | 0 |
| 1985 | 40 | 0 |
| 1986 | 69 | 0 |
| 1987 | 77 | 0 |
| 1988 | 50 | 0 |
| 1989 | 91 | 0 |
| 1990 | 108 | 0 |
| 1991 | 104 | 0 |
| 1992 | 94 | 0 |
| 1993 | 74 | 0 |
| 1994 | 106 | 0 |
| 1995 | 115 | 0 |
| 1996 | 94 | 0 |
| 1997 | 147 | 0 |
| 1998 | 150 | 0 |
| 1999 | 219 | 0 |
| 2000 | 209 | 0 |
| 2001 | 274 | 70 |
| 2002 | 300 | 401 |
| 2003 | 290 | 782 |
| 2004 | 263 | 1052 |
| 2005 | 283 | 924 |
| 2006 | 421 | 1013 |
| 2007 | 461 | 1100 |
| 2008 | 451 | 1079 |
| 2009 | 626 | 1336 |
| 2010 | 730 | 1538 |
| 2011 | 777 | 1351 |
| 2012 | 916 | 1360 |
| 2013 | 978 | 1087 |
| 2014 | 958 | 1091 |
| 2015 | 818 | 940 |
| 2016 | 725 | 870 |
| 2017 | 716 | 785 |
| 2018 | 596 | 697 |
| 2019 | 548 | 671 |
| 2020 | 444 | 506 |
| 2021 | 373 | 437 |
| 2022 | 244 | 374 |
| 2023 | 202 | 320 |
| 2024 | 196 | 341 |
| 2025 | 177 | 259 |
| 2026 | 92 | 172 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for prevention, amelioration, or treatment of hypersensitivity immune disease containing galactose6 Oct 2026US 12,751,961 B2Quorum Bio Co., Ltd.
- Extract of bacteria of the genus Sphingomonas29 Sep 2026US 12,746,260 B2L'oreal
- Spinning solution, and alginate fiber comprising cannabidiol, method for producing the same, and use thereof22 Sep 2026US 12,740,946 B2Pell Bio-Med Technology Co., Ltd.
- Immune cell receptor antibodies conjugated to high affinity siglec-ligands8 Sep 2026US 12,728,169 B2The Scripps Research Institute
- Methods for preventing an immunoglobulin e-related disease25 Aug 2026US 12,714,736 B2My-Or Diagnostics Ltd.
- Treatment of peanut allergy with tolerizing nanoparticles8 Oct 2026US 2026/0306622 A1Cour Pharmaceuticals Development Company, Inc.
- Treatment of food allergy using anti-ige antibodies8 Oct 2026US 2026/0308280 A1Novartis AG
- Vaccine for treating allergies1 Oct 2026US 2026/0295036 A1Worg Pharmaceuticals (Zhejiang) Co., Ltd.
- Anti-allergen antibodies and uses thereof1 Oct 2026US 2026/0297169 A1
- Compositions and method for management of pain and allergy24 Sep 2026US 2026/0284003 A1
Most cited
By later US patents
- Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same547US 5,130,302 ABoron Bilogicals, Inc. · 1992
- Immunostimulatory nucleic acid molecules472US 6,207,646 B1Coley Pharmaceutical Group, Inc. · 2001
- Immunostimulatory nucleic acid molecules461US 6,239,116 B1Coley Pharmaceutical Group, Inc. · 2001
- Human antibodies that bind human TNF.alpha.451US 6,090,382 ABASF SE · 2000
- Antibodies against PD-1450US 7,488,802 B2MedImmune, LLC · 2009